Skip to main content

Educational information

GLP-1 treatments we can help you get evaluated for

Semaglutide and tirzepatide are prescription-only medications. Nothing on this page is a recommendation to take them. Only a licensed provider can decide whether either medication is appropriate for you after reviewing your health history, current medications, and conditions.

Semaglutide

Unbranded medical vial labeled GLP-1 Semaglutide

What it is

A GLP-1 receptor agonist. It mimics the GLP-1 hormone the body naturally produces.

How it works

It helps regulate appetite and food intake and slows gastric emptying, and it supports blood-sugar regulation. Clinicians prescribe it for eligible adults for type 2 diabetes management and, in appropriate cases, chronic weight management.

How it's taken

Typically a once-weekly subcutaneous injection, with dosing determined by the prescribing provider.

Who it may not be for, and what the provider screens

The reviewing provider will screen your history, including things like a personal or family history of medullary thyroid carcinoma or MEN2, history of pancreatitis, pregnancy or breastfeeding, and current medications.

Common side effects

Nausea, vomiting, diarrhea, constipation, and abdominal discomfort are among those reported. This is not a complete list. Discuss all risks with your provider and report unusual reactions immediately.

Semaglutide is a prescription-only medication. Individual results vary. This information is educational and is not medical advice. Only a licensed provider can determine whether treatment is appropriate for you.

Tirzepatide

Unbranded medical vial labeled GLP-1 Tirzepatide

What it is

A dual GIP and GLP-1 receptor agonist.

How it works

It acts on two gut-hormone receptor pathways involved in appetite regulation and blood-sugar control.

How it's taken

Typically a once-weekly subcutaneous injection, with dosing determined by the prescribing provider.

Who it may not be for, and what the provider screens

The reviewing provider will screen your history, including things like a personal or family history of medullary thyroid carcinoma or MEN2, history of pancreatitis, pregnancy or breastfeeding, and current medications.

Common side effects

Nausea, diarrhea, decreased appetite, vomiting, constipation, and abdominal discomfort are among those reported. This is not a complete list. Discuss all risks with your provider and report unusual reactions immediately.

Tirzepatide is a prescription-only medication. Individual results vary. This information is educational and is not medical advice. Only a licensed provider can determine whether treatment is appropriate for you.

Start your evaluation

A licensed provider reviews your intake and issues a prescription only when it is clinically appropriate. Completing an intake does not guarantee a prescription.

A doctor may request a video call if needed.

Prescription-only medication. Provider evaluation required. Adults 18+. Available in 49 U.S. states.

A doctor may request a video call if needed.